•Japan's Ministry of Health, Labour and Welfare (MHLW) granted marketing approval for Alpha DaRT for treating locally advanced or recurrent head and neck cancer.
•This approval represents the first clinical authorization for the technology outside of Israel.
•The company will initiate a post-market surveillance program in Japan as part of the rollout.
•The US Supreme Court delivered a 6–3 decision in Learning Resources, Inc. v. Trump, striking down the use of the International Emergency Economic Powers Act (IEEPA) for global tariffs.
•Gold prices surged by 2.4% following the judicial decision.
•The market is monitoring a 150-day clock regarding potential 'Plan B' alternatives for new import taxes.
